申请人:EMERGENT PRODUCT DEVELOPMENT SEATTLE, LLC
公开号:US20130280240A1
公开(公告)日:2013-10-24
Immunoglycoproteins, including antibodies, with improved ADCC and altered glycosylation patterns arc provided. Also provided are cell culturing methods and media for producing such immunoglycoproteins, and therapeutic uses of such immunoglycoproteins.